Skip to main content
Premium Trial:

Request an Annual Quote

Here's a Shocker: Accuracy of Genetic Tests Called Into Question

Given the explosion of DNA testing news lately, it's no surprise to see an article about the downside of genetic tests. This piece from the New York Times chronicles the work of Harvard professor Henry Louis Gates Jr., who has helped bring genetic testing into the vernacular but has also become a strong critic of the field after tests of his own DNA gave conflicting results.

John Hawks took the opportunity to remind readers that he has for years issued warnings about the reliability of genetic test results. It's not just flawed science, either -- "It's also a case where there are a lot of vested interests in being able to give people the results they want to hear," he writes.

Despite (or perhaps because of) these problems, Gates is starting his own company in the space; it will focus on DNA testing for African Americans, and you can read more about it at Blaine Bettinger's blog.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.